These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 17363567)

  • 21. Leptin induces cyclin D1 expression and proliferation of human nucleus pulposus cells via JAK/STAT, PI3K/Akt and MEK/ERK pathways.
    Li Z; Shen J; Wu WK; Yu X; Liang J; Qiu G; Liu J
    PLoS One; 2012; 7(12):e53176. PubMed ID: 23300886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways.
    Chen C; Chang YC; Lan MS; Breslin M
    Int J Oncol; 2013 Mar; 42(3):1113-9. PubMed ID: 23354006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circular RNA circCDK13 suppresses cell proliferation, migration and invasion by modulating the JAK/STAT and PI3K/AKT pathways in liver cancer.
    Lin Q; Ling YB; Chen JW; Zhou CR; Chen J; Li X; Huang MS
    Int J Oncol; 2018 Jul; 53(1):246-256. PubMed ID: 29658568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways.
    Bao L; Yan Y; Xu C; Ji W; Shen S; Xu G; Zeng Y; Sun B; Qian H; Chen L; Wu M; Su C; Chen J
    Cancer Lett; 2013 Sep; 337(2):226-36. PubMed ID: 23684551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leptin activates STAT3 and ERK1/2 pathways and induces endometrial cancer cell proliferation.
    Liu Y; Lv L; Xiao W; Gong C; Yin J; Wang D; Sheng H
    J Huazhong Univ Sci Technolog Med Sci; 2011 Jun; 31(3):365. PubMed ID: 21671179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling.
    Wang Z; Qu L; Deng B; Sun X; Wu S; Liao J; Fan J; Peng Z
    Sci Rep; 2016 Sep; 6():33205. PubMed ID: 27628214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulating RISK: a role for JAK-STAT signaling in postconditioning?
    Goodman MD; Koch SE; Fuller-Bicer GA; Butler KL
    Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1649-56. PubMed ID: 18708442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of PI3K/Akt and ERK signaling decreases visfatin-induced invasion in liver cancer cells.
    Miethe C; Torres L; Zamora M; Price RS
    Horm Mol Biol Clin Investig; 2021 Aug; 42(4):357-366. PubMed ID: 34449178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA ANRIL promotes cell growth, migration and invasion of hepatocellular carcinoma cells via sponging miR-144.
    Ma Y; Zhang H; Li G; Hu J; Liu X; Lin L
    Anticancer Drugs; 2019 Nov; 30(10):1013-1021. PubMed ID: 31609763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. APPL1-Mediating Leptin Signaling Contributes to Proliferation and Migration of Cancer Cells.
    Ding Y; Cao Y; Wang B; Wang L; Zhang Y; Zhang D; Chen X; Li M; Wang C
    PLoS One; 2016; 11(11):e0166172. PubMed ID: 27820851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bisphenol A induces leptin receptor expression, creating more binding sites for leptin, and activates the JAK/Stat, MAPK/ERK and PI3K/Akt signalling pathways in human ovarian cancer cell.
    Ptak A; Gregoraszczuk EL
    Toxicol Lett; 2012 May; 210(3):332-7. PubMed ID: 22343039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase.
    Stefanou N; Papanikolaou V; Furukawa Y; Nakamura Y; Tsezou A
    BMC Cancer; 2010 Aug; 10():442. PubMed ID: 20723213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethanol-TGFalpha-MEK signaling promotes growth of human hepatocellular carcinoma.
    Hennig M; Yip-Schneider MT; Klein P; Wentz S; Matos JM; Doyle C; Choi J; Wu H; O'Mara A; Menze A; Noble S; McKillop IH; Schmidt CM
    J Surg Res; 2009 Jun; 154(2):187-95. PubMed ID: 19321179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway.
    Tian T; Nan KJ; Guo H; Wang WJ; Ruan ZP; Wang SH; Liang X; Lu CX
    Oncol Rep; 2010 Jun; 23(6):1593-600. PubMed ID: 20428814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. cPLA2α activates PI3K/AKT and inhibits Smad2/3 during epithelial-mesenchymal transition of hepatocellular carcinoma cells.
    Fu H; He Y; Qi L; Chen L; Luo Y; Chen L; Li Y; Zhang N; Guo H
    Cancer Lett; 2017 Sep; 403():260-270. PubMed ID: 28649002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway.
    Zhang Z; Zhu J; Huang Y; Li W; Cheng H
    Diagn Pathol; 2018 Nov; 13(1):85. PubMed ID: 30390677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of leptin and its mechanisms on the migration and invasion of human breast cancer MCF-7 cells].
    Wang L; Cao H; Pang X; Li K; Dang W; Tang H; Chen T
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Dec; 29(12):1272-6. PubMed ID: 24321071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation.
    Ogunwobi O; Mutungi G; Beales IL
    Endocrinology; 2006 Sep; 147(9):4505-16. PubMed ID: 16740977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eukaryotic elongation factor 2 kinase promotes angiogenesis in hepatocellular carcinoma via PI3K/Akt and STAT3.
    Zhou Y; Li Y; Xu S; Lu J; Zhu Z; Chen S; Tan Y; He P; Xu J; Proud CG; Xie J; Shen K
    Int J Cancer; 2020 Mar; 146(5):1383-1395. PubMed ID: 31286509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heat shock protein 22 (HSPB8) reduces the migration of hepatocellular carcinoma cells through the suppression of the phosphoinositide 3-kinase (PI3K)/AKT pathway.
    Matsushima-Nishiwaki R; Toyoda H; Takamatsu R; Yasuda E; Okuda S; Maeda A; Kaneoka Y; Yoshimi N; Kumada T; Kozawa O
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1629-1639. PubMed ID: 28456666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.